Pentes s.r.o.

Research site

Slovakia Halkova 3, 010 01 Zilina, Slovakia

1 trial recruiting
Arteriosclerosis
Adult patients

About Specializations

Pentes s.r.o. in Zilina, Slovakia specialises in clinical trials of conditions such as Arteriosclerosis, and other specialisations. This site conducts important research.

Arteriosclerosis

Main research areas of the site

Cardiovascular Research

The medical center is at the forefront of cardiovascular research, focusing on innovative treatments for atherosclerotic cardiovascular disease (ASCVD). The center's research aims to reduce the risk of major adverse cardiovascular events, such as heart attacks and strokes, in patients with established vascular conditions.

Prevention of cardiovascular death
Reduction of heart attacks
Minimization of stroke risk

Through its pioneering work, the center contributes significantly to the development of therapies that improve patient outcomes and enhance quality of life for those with cardiovascular diseases.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

Halkova 3010 01 ZilinaSlovakia

Open in maps ↗

Recruiting now: 1 trial
Conditions studied: 1

More sites in Zilina Slovakia

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Quick filters

4 clinical trials

Arteriosclerosis

Recruiting

Study of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease

Investigational

Study of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease

Investigational

Slovakia

Participants:18–64 years · 65+ years
Substances:Maridebart Cafraglutide
Sponsor:Amgen Inc.

Contact Research Centre

Arteriosclerosis

Not yet recruiting

Study of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)

Investigational

Study of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)

Investigational

Slovakia

Participants:18–64 years · 65+ years
Sponsor:Amgen Inc.

Contact Research Centre

Arteriosclerosis

Not recruiting

Study on the Effects of Pelacarsen on Heart Disease in Patients with Cardiovascular Conditions

Investigational

Study on the Effects of Pelacarsen on Heart Disease in Patients with Cardiovascular Conditions

Investigational

Slovakia

Participants:18–64 years · 65+ years
Substances:Pelacarsen
Sponsor:Novartis Pharma AG

Contact Research Centre

Arteriosclerosis

Not recruiting

Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease

Registered drug

Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease

Registered drug

Slovakia

Participants:18–64 years · 65+ years
Substances:Atorvastatin
Sponsor:Novartis Pharma AG

Contact Research Centre

Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites